Respiratory Pharm Flashcards
describe asthma
- Chronic inflammation of the airways
- Bronchial hyperresponsiveness
- Airflow obstruction
- reversible
inflammation in airway secretion from asthma results in
- Bronchiolar Smooth Muscle Spasm
- Airway Hyperresponsiveness
- Airway Edema
- Increased Mucus Secretion
classify asthma based on severity
overview of drugs for asthma management
list the inhaled short-acting β2 adrenergic agonists (SABAs)
Albuterol
Terbutaline
Pirbuterol
list the Inhaled long-acting β2 adrenergic agonists (LABAs)
Salmeterol
Formoterol
describe the MOA of β2 Adrenergic Agonists
- Binds/activates β2 adrenergic receptors on airway smooth muscle cells
- Activation of β2 receptors stimulates adenylyl cyclase and increases formation of cAMP
- cAMP activates protein kinase A which phosphorylates and inactivates myosin light chain kinase → relaxation of the airway smooth muscle cells and bronchodilation
___ are the DOC for relief of acute asthma symptoms and prevention of exercise-induced bronchospasm
SABAs are the DOC for relief of acute asthma symptoms and prevention of exercise-induced bronchospasm
LABAs are combined with ____ for long-term control in moderate and severe persistent asthma
LABAs shouldn’t be used as ___ for long-term control of asthma as they have no _____
Are LABAs used for treating acute asthma symptoms?
LABAs are combined with inhaled corticosteroids (ICS) for long-term control in moderate and severe persistent asthma
LABAs shouldn’t be used as monotherapy for long-term control of asthma as they have no anti-inflammatory action
LABAs are NOT used for acute astham symptoms
list AEs of β2 Adrenergic Agonists
-
tachycardia, tremor, and hypokalemia
- reduced via inhalation administration
- LABAs increase risk of serious asthma- related events (hospitalization, intubation, and death)
list the Inhaled Short-Acting Muscarinic Antagonists (SAMAs)
Ipratropium
list the Inhaled Long-Acting Muscarinic Antagonists (LAMAs)
Tiotropium
what is the MOA of ipratropium and tiotropium
block muscarinic receptors on the airways causing bronchodilation and reduction of respiratory secretions
Ipratropium is less effective than ____
but provides additive benefit to SABAs in the management of moderate to severe exacerbations of asthma
Ipratropium is less effective than SABAs
but provides additive benefit to SABAs in the management of moderate to severe exacerbations of asthma
____ is the DOC for β-blocker-induced bronchospasm
Ipratropium is the DOC for β-blocker-induced bronchospasm
____ may be added to ICS for long-term control of severe persistent asthma
Tiotropium may be added to ICS for long-term control of severe persistent asthma
list the Anticholinergic AEs
- quaternary ammonium compounds
- minor anticholinergic effects, e.g. xerostomia
- may be safer than SABAs in patients with cardiovascular disease
Methylxanthines
Theophylline
Theophylline inhibits ____, increasing ____ evoking bronchodilation
Theophylline inhibits phosphodiesterase, increasing cAMP evoking bronchodilation